Endocrinology, Vol 122, 609-617, Copyright © 1988 by Endocrine Society

ARTICLES

Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides

EL Webster and EB De Souza
Neuroscience Branch, National Institute on Drug Abuse, Baltimore, Maryland 21224.

The radioligand [125I-Tyro]ovine CRF [( 125I] oCRF) was used to identify, characterize, and localize CRF receptors in a crude homogenate of mouse spleen. The binding was linear with increasing membrane protein concentration, saturable, and of high affinity. Scatchard analysis of [125I]oCRF saturation curves revealed a high affinity component with an apparent dissociation constant of 0.26 nM and a maximum receptor concentration of 8.74 fmol/mg protein. The relative affinities of various CRF-related and unrelated peptides at the [125I]oCRF-binding site in spleen correlate well with their reported potencies in eliciting ACTH release from the pituitary and their relative affinities for CRF receptors in brain. Consistent with a coupling of splenic CRF receptors to a guanine nucleotide regulatory protein, the binding of [125I]oCRF was increased by magnesium ions and decreased by guanine nucleotides in both mouse spleen and brain. Saturation analysis of [125I]oCRF binding at 0, 1, and 10 mM MgCl2, 10 mM MgCl2 plus 200 microM GTP, and 10 mM MgCl2 plus 50 microM 5'- guanylimidodiphosphate indicated that high affinity [125I]oCRF binding in both brain and spleen requires Mg2+; however, subtle differences were observed in the degree of sensitivity and mechanisms by which Mg2+ and guanine nucleotides regulated specific binding of [125I]oCRF to brain and spleen. Autoradiographic studies indicated that [125I]oCRF- binding sites were primarily localized to the red pulp and marginal zone regions of the spleen, which are known to contain high concentrations of macrophages. The absence of [125I]oCRF-binding sites in the periarteriolar and peripheral follicular white pulp regions suggests that neither T nor B lymphocytes have specific CRF-binding sites. In summary, we have identified a high affinity, magnesium- dependent, and guanine nucleotide-sensitive binding site for CRF in mouse spleen which appears to be localized primarily in splenic macrophages.

This article has been cited by other articles:

				H. Ikushima, M. Kanaoka, and S. Kojima Cutting Edge: Requirement for Growth Hormone-Releasing Hormone in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., September 15, 2003; 171(6): 2769 - 2772. [Abstract] [Full Text] [PDF]

				S. E. Murray, H. R. Lallman, A. D. Heard, M. B. Rittenberg, and M. P. Stenzel-Poore A Genetic Model of Stress Displays Decreased Lymphocytes and Impaired Antibody Responses Without Altered Susceptibility to Streptococcus pneumoniae J. Immunol., July 15, 2001; 167(2): 691 - 698. [Abstract] [Full Text] [PDF]

				Y. E. Tian, L.-H. Wu, W. T. Mueller, and F.-Z. Chung A Screening Strategy Based on Differential Binding of Ligand to Receptor and to Binding Proteins: Screening for Compounds Interacting with Corticotrophin-Releasing Factor-Binding Protein J Biomol Screen, December 1, 1999; 4(6): 319 - 326. [Abstract] [PDF]

				K Karalis, H Sano, J Redwine, S Listwak, R. Wilder, and G. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science, October 18, 1991; 254(5030): 421 - 423. [Abstract] [PDF]